Intravenous Lidocaine for Laparoscopic Cholecystectomy
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Intravenous lidocaine has been shown to have analgesic, antinflammatory, antihyperalgesic,
antithrombotics and neuroprotective properties. In a previous study conducted in patients
undergoing laparoscopic cholecystectomy under general anesthesia with desflurane and
fentanyl, intraoperative i.v. infusion of lidocaine spared opioids consumption in the
recovery room by 30%.
The purpose of this study was to determine if an i.v. infusion of lidocaine without
intraoperative opioids would reduce the amount of fentanyl to the same extent and
opioids-related side effects.
Phase:
N/A
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre